Chargement en cours...
Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-β
Vaccinia virus (VV) has been used extensively as a vaccine vehicle in the clinical application for infectious diseases and cancer. Previous studies have suggested that the unique potency of VV-based vaccine lies in its effective activation of the innate immune system. However, how VV activates innat...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Hematology
2007
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1785085/ https://ncbi.nlm.nih.gov/pubmed/16973959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-06-027136 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|